Cargando…
Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin–Therapy: A 6-Year Retrospective Study
Background: Statins are associated with new-onset type 2 diabetes (T2D), mainly in patients with metabolic syndrome (MetS). The fatty liver index (FLI) is used as a prognostic score for the diagnosis of non-alcoholic fatty liver disease (NAFLD), which is common in patients with MetS. We aimed to inv...
Autores principales: | Anastasiou, Georgia, Liberopoulos, Evangelos, Petkou, Ermioni, Koutsogianni, Amalia Despoina, Adamidis, Petros Spyridwnas, Liamis, George, Ntzani, Evangelia, Barkas, Fotios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913972/ https://www.ncbi.nlm.nih.gov/pubmed/36766607 http://dx.doi.org/10.3390/diagnostics13030503 |
Ejemplares similares
-
Statin-associated side effects in patients attending a lipid clinic: evidence from a 6-year study
por: Barkas, Fotios, et al.
Publicado: (2021) -
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2022) -
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2023) -
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
por: Barkas, Fotios, et al.
Publicado: (2021) -
Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
por: Barkas, Fotios, et al.
Publicado: (2021)